Krystal Biotech, Inc. (KRYS) Social Stream
KRYSTAL BIOTECH INC (KRYS) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering KRYS.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 4 | $123 | $89 | $105 | $129.01 | -18.61% |
| 2021-11-30 | 5 | $140 | $111 | $125 | $129.01 | -3.11% |
| 2022-02-28 | 5 | $140 | $110 | $121.25 | $129.01 | -6.02% |
| 2022-03-04 | 5 | $140 | $107 | $117 | $129.01 | -9.31% |
| 2022-03-22 | 5 | $137 | $107 | $116.25 | $129.01 | -9.89% |
| 2022-05-11 | 5 | $137 | $101 | $113.2 | $129.01 | -12.25% |
| 2022-05-13 | 6 | $137 | $95 | $110.2 | $129.01 | -14.58% |
| 2022-08-08 | 6 | $137 | $78 | $104.833 | $129.01 | -18.74% |
| 2022-08-13 | 6 | $130 | $78 | $103.666 | $129.01 | -19.64% |
| 2022-10-03 | 6 | $130 | $74 | $103 | $129.01 | -20.16% |
| 2023-02-08 | 6 | $133 | $74 | $105.5 | $129.01 | -18.22% |
| 2023-02-28 | 7 | $133 | $74 | $105.5 | $129.01 | -18.22% |
| 2023-03-01 | 7 | $133 | $101 | $115.5 | $129.01 | -10.47% |
| 2023-04-18 | 8 | $133 | $101 | $115.5 | $129.01 | -10.47% |
| 2023-05-10 | 8 | $133 | $95 | $112.142 | $129.01 | -13.07% |
| 2023-05-12 | 8 | $133 | $101 | $113.571 | $129.01 | -11.97% |
| 2023-05-22 | 8 | $139 | $95 | $115 | $129.01 | -10.86% |
| 2023-05-23 | 8 | $155 | $102 | $129.857 | $129.01 | 0.66% |
| 2023-06-06 | 8 | $155 | $130 | $141 | $129.01 | 9.29% |
| 2023-08-07 | 8 | $160 | $130 | $145.285 | $129.01 | 12.62% |
| 2023-08-11 | 8 | $160 | $130 | $146.714 | $129.01 | 13.72% |
| 2023-09-26 | 9 | $160 | $130 | $146.571 | $129.01 | 13.61% |
| 2023-10-12 | 9 | $160 | $130 | $148.25 | $129.01 | 14.91% |
| 2023-10-24 | 10 | $160 | $130 | $148.25 | $129.01 | 14.91% |
| 2023-11-08 | 11 | $160 | $130 | $149.555 | $129.01 | 15.93% |
| 2023-11-20 | 11 | $160 | $130 | $150.6 | $129.01 | 16.74% |
| 2023-12-13 | 11 | $180 | $130 | $152.6 | $129.01 | 18.29% |
The Trend in the Analyst Price Target
KRYS's average price target has moved up $31.35 over the prior 22 months.
Over the past 48 weeks, KRYS's average upside potential has been 28.12%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-28 | 7 | 133 | 74 | 105.500 | 81.91 | 28.8% |
| 2023-05-25 | 8 | 155 | 130 | 141.000 | 117.39 | 20.11% |
| 2023-09-26 | 8 | 160 | 130 | 146.571 | 115.35 | 27.07% |
| 2023-10-12 | 9 | 160 | 130 | 148.250 | 110.85 | 33.74% |
| 2023-11-08 | 10 | 160 | 130 | 149.555 | 102.25 | 46.26% |
KRYS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 11 | 0 | 0 | 0 | 0 | 11 |
The Trend in the Broker Recommendations
KRYS's average broker recommendation rating improved by 0 over the prior 16 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- KRYS has a higher average analyst price target than 3015.35% of stocks in the mid market cap category.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, KRYSTAL BIOTECH INC's upside potential (average analyst target price relative to current price) is higher than 464.42% of them.
- In the context of Pharmaceutical Products stocks, KRYSTAL BIOTECH INC's variance in analysts' estimates is lower than -484.1% of them.
- In the context of stocks in the mid market cap category, KRYSTAL BIOTECH INC's number of analysts covering the stock is higher than 1436.13% of them.
Stocks similar to KRYSTAL BIOTECH INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are MESO, IOVA, and ALVR.
View All Top Stocks by Price Target
Is KRYS a Buy, Hold or Sell? See the POWR Ratings now!